

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to cadmium ion (GO:0071276) | 7.35437908 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 6.12077080 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 5.57748933 |
| 4 | regulation of fibrinolysis (GO:0051917) | 5.23659514 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.79562414 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.79562414 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.42187128 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.42187128 |
| 9 | complement activation, alternative pathway (GO:0006957) | 4.31811923 |
| 10 | * response to zinc ion (GO:0010043) | 4.06771273 |
| 11 | fibrinolysis (GO:0042730) | 3.85090086 |
| 12 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79641261 |
| 13 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79641261 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 3.78088995 |
| 15 | negative regulation of platelet activation (GO:0010544) | 3.75614247 |
| 16 | acute-phase response (GO:0006953) | 3.62170541 |
| 17 | regulation of plasminogen activation (GO:0010755) | 3.57177156 |
| 18 | negative regulation of hemostasis (GO:1900047) | 3.48216034 |
| 19 | negative regulation of blood coagulation (GO:0030195) | 3.48216034 |
| 20 | cellular copper ion homeostasis (GO:0006878) | 3.47943671 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 3.43204238 |
| 22 | negative regulation of coagulation (GO:0050819) | 3.37694107 |
| 23 | plasma lipoprotein particle clearance (GO:0034381) | 3.35149720 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.30306153 |
| 25 | positive regulation of p38MAPK cascade (GO:1900745) | 3.25360927 |
| 26 | positive regulation of lipid storage (GO:0010884) | 3.21701236 |
| 27 | regulation of complement activation (GO:0030449) | 3.21100916 |
| 28 | oxaloacetate metabolic process (GO:0006107) | 3.20865988 |
| 29 | daunorubicin metabolic process (GO:0044597) | 3.12118793 |
| 30 | polyketide metabolic process (GO:0030638) | 3.12118793 |
| 31 | doxorubicin metabolic process (GO:0044598) | 3.12118793 |
| 32 | positive regulation of blood coagulation (GO:0030194) | 3.12050967 |
| 33 | positive regulation of hemostasis (GO:1900048) | 3.12050967 |
| 34 | cellular response to arsenic-containing substance (GO:0071243) | 3.09765330 |
| 35 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05055130 |
| 36 | triglyceride catabolic process (GO:0019433) | 3.04758491 |
| 37 | negative regulation of wound healing (GO:0061045) | 3.00470864 |
| 38 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.97913119 |
| 39 | * response to cadmium ion (GO:0046686) | 2.94522030 |
| 40 | positive regulation of coagulation (GO:0050820) | 2.94395153 |
| 41 | protein carboxylation (GO:0018214) | 2.93312127 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93312127 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 2.90728615 |
| 44 | ovulation from ovarian follicle (GO:0001542) | 2.84826428 |
| 45 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.84124088 |
| 46 | lipid storage (GO:0019915) | 2.84094575 |
| 47 | negative regulation of necroptotic process (GO:0060546) | 2.82788531 |
| 48 | positive regulation of wound healing (GO:0090303) | 2.82725633 |
| 49 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.82359690 |
| 50 | pyrimidine-containing compound salvage (GO:0008655) | 2.82311469 |
| 51 | pyrimidine nucleoside salvage (GO:0043097) | 2.82311469 |
| 52 | acylglycerol catabolic process (GO:0046464) | 2.81592897 |
| 53 | neutral lipid catabolic process (GO:0046461) | 2.81592897 |
| 54 | regulation of mononuclear cell migration (GO:0071675) | 2.77740964 |
| 55 | actin-myosin filament sliding (GO:0033275) | 2.76851778 |
| 56 | muscle filament sliding (GO:0030049) | 2.76851778 |
| 57 | cofactor catabolic process (GO:0051187) | 2.75547680 |
| 58 | triglyceride homeostasis (GO:0070328) | 2.74103136 |
| 59 | acylglycerol homeostasis (GO:0055090) | 2.74103136 |
| 60 | regulation of metalloenzyme activity (GO:0048552) | 2.73909043 |
| 61 | acute inflammatory response (GO:0002526) | 2.73518170 |
| 62 | response to muscle activity (GO:0014850) | 2.73493775 |
| 63 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.73139785 |
| 64 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.71209003 |
| 65 | regulation of macrophage chemotaxis (GO:0010758) | 2.70826290 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 2.69087486 |
| 67 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.68382885 |
| 68 | NADH metabolic process (GO:0006734) | 2.68086448 |
| 69 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.68043829 |
| 70 | regulation of triglyceride metabolic process (GO:0090207) | 2.65210255 |
| 71 | copper ion homeostasis (GO:0055070) | 2.63426932 |
| 72 | ethanol oxidation (GO:0006069) | 2.62597098 |
| 73 | urea metabolic process (GO:0019627) | 2.59449216 |
| 74 | regulation of p38MAPK cascade (GO:1900744) | 2.59442126 |
| 75 | coenzyme catabolic process (GO:0009109) | 2.56704443 |
| 76 | negative regulation of protein autophosphorylation (GO:0031953) | 2.53151890 |
| 77 | regulation of oxidative phosphorylation (GO:0002082) | 2.51377516 |
| 78 | barbed-end actin filament capping (GO:0051016) | 2.50875132 |
| 79 | omega-hydroxylase P450 pathway (GO:0097267) | 2.50308934 |
| 80 | positive regulation of extracellular matrix organization (GO:1903055) | 2.50270841 |
| 81 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.49654106 |
| 82 | activation of protein kinase B activity (GO:0032148) | 2.47870361 |
| 83 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47457541 |
| 84 | urea cycle (GO:0000050) | 2.46019475 |
| 85 | fatty acid homeostasis (GO:0055089) | 2.45828692 |
| 86 | negative regulation of lipid storage (GO:0010888) | 2.45819252 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 2.45234069 |
| 88 | retinal metabolic process (GO:0042574) | 2.44937657 |
| 89 | opsonization (GO:0008228) | 2.44464555 |
| 90 | adhesion of symbiont to host (GO:0044406) | 2.44253439 |
| 91 | regulation of lipid storage (GO:0010883) | 2.42084150 |
| 92 | epoxygenase P450 pathway (GO:0019373) | 2.41753041 |
| 93 | skeletal muscle contraction (GO:0003009) | 2.41686806 |
| 94 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40171792 |
| 95 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.39417336 |
| 96 | heart trabecula formation (GO:0060347) | 2.38795907 |
| 97 | lung vasculature development (GO:0060426) | 2.35631155 |
| 98 | membrane raft organization (GO:0031579) | 2.35195246 |
| 99 | brown fat cell differentiation (GO:0050873) | 2.34531274 |
| 100 | * cellular response to zinc ion (GO:0071294) | 11.9406163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.06515150 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.50189519 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.78716862 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.37238237 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.25754079 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23177325 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.20795430 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.98309746 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.79449460 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.75725269 |
| 11 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57631995 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56397871 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46304058 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.44661070 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36405619 |
| 16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.35262499 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32553563 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30458159 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23390438 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22272768 |
| 21 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.12303831 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07175952 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01472057 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95184508 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88658504 |
| 26 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.83106088 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82588384 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72782881 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72117617 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58079532 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55763188 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.51658733 |
| 33 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47784830 |
| 34 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46660631 |
| 35 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44854711 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.43351277 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42507052 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41296278 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39768859 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37856320 |
| 41 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36325454 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36325454 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35859302 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.33464682 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31021670 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27827472 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27827472 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25766171 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24748544 |
| 50 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.24318760 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23304188 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19806571 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19464438 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19231464 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17188310 |
| 56 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15236647 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15211488 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14568261 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11800543 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10322077 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09416215 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07864968 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06688847 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05935185 |
| 65 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.03666928 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02870578 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02847239 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99484616 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98926790 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97991502 |
| 71 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97919780 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96370275 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96199988 |
| 74 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95423051 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95265340 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94693949 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93944855 |
| 78 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93125664 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92890003 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91790398 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91490804 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89372897 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89151951 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88151768 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87537045 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87329881 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85459852 |
| 88 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85148764 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84290212 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83217355 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82890374 |
| 92 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.82579283 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81261696 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79938326 |
| 95 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.79300229 |
| 96 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.79275138 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79062572 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78314377 |
| 99 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78240204 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77955504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.09577499 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.34619231 |
| 3 | MP0009840_abnormal_foam_cell | 3.32791323 |
| 4 | MP0005451_abnormal_body_composition | 3.16730627 |
| 5 | MP0000343_altered_response_to | 2.76499275 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.76436266 |
| 7 | MP0003011_delayed_dark_adaptation | 2.73730090 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.61822686 |
| 9 | MP0005670_abnormal_white_adipose | 2.59672413 |
| 10 | MP0004510_myositis | 2.44368310 |
| 11 | MP0005360_urolithiasis | 2.25662733 |
| 12 | MP0000751_myopathy | 2.18652772 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.17202284 |
| 14 | MP0003195_calcinosis | 2.15997765 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.15813023 |
| 16 | MP0005365_abnormal_bile_salt | 2.15306238 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10817570 |
| 18 | MP0008004_abnormal_stomach_pH | 2.10142972 |
| 19 | MP0000749_muscle_degeneration | 1.99959466 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.91480247 |
| 21 | MP0005666_abnormal_adipose_tissue | 1.82898764 |
| 22 | MP0005164_abnormal_response_to | 1.82123347 |
| 23 | MP0003724_increased_susceptibility_to | 1.80701810 |
| 24 | MP0003075_altered_response_to | 1.79796197 |
| 25 | MP0003828_pulmonary_edema | 1.78244846 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.76154616 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.74982140 |
| 28 | MP0003186_abnormal_redox_activity | 1.74925076 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.73355686 |
| 30 | MP0002971_abnormal_brown_adipose | 1.73263384 |
| 31 | MP0005330_cardiomyopathy | 1.70372565 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.69704014 |
| 33 | MP0005165_increased_susceptibility_to | 1.60970170 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.60529058 |
| 35 | MP0009785_altered_susceptibility_to | 1.52147618 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.47954187 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.47118408 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.41225878 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.40166959 |
| 40 | MP0006138_congestive_heart_failure | 1.38991036 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.38611545 |
| 42 | MP0001853_heart_inflammation | 1.36405641 |
| 43 | MP0003646_muscle_fatigue | 1.33338486 |
| 44 | MP0009697_abnormal_copulation | 1.28590444 |
| 45 | MP0003868_abnormal_feces_composition | 1.28042857 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.24860613 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.23944856 |
| 48 | MP0005334_abnormal_fat_pad | 1.22980893 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.21612014 |
| 50 | MP0005535_abnormal_body_temperature | 1.20587392 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.20279123 |
| 52 | MP0005332_abnormal_amino_acid | 1.18300476 |
| 53 | MP0000609_abnormal_liver_physiology | 1.17917492 |
| 54 | MP0005085_abnormal_gallbladder_physiolo | 1.16590494 |
| 55 | MP0001764_abnormal_homeostasis | 1.16222126 |
| 56 | MP0002972_abnormal_cardiac_muscle | 1.15683994 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.15194060 |
| 58 | MP0003303_peritoneal_inflammation | 1.14671292 |
| 59 | MP0005023_abnormal_wound_healing | 1.13893406 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 1.11611144 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.11525241 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.08936692 |
| 63 | MP0005266_abnormal_metabolism | 1.08759919 |
| 64 | MP0002970_abnormal_white_adipose | 1.08541675 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.08520793 |
| 66 | MP0000747_muscle_weakness | 1.07324429 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.03542942 |
| 68 | MP0005166_decreased_susceptibility_to | 1.03495122 |
| 69 | MP0005595_abnormal_vascular_smooth | 1.02298828 |
| 70 | MP0009764_decreased_sensitivity_to | 0.99203448 |
| 71 | MP0003436_decreased_susceptibility_to | 0.98689357 |
| 72 | MP0000733_abnormal_muscle_development | 0.97593115 |
| 73 | MP0004215_abnormal_myocardial_fiber | 0.97458535 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97297052 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 0.95908250 |
| 76 | MP0009115_abnormal_fat_cell | 0.95885987 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.95743009 |
| 78 | MP0001661_extended_life_span | 0.95712990 |
| 79 | MP0001542_abnormal_bone_strength | 0.95369154 |
| 80 | MP0002269_muscular_atrophy | 0.94202346 |
| 81 | MP0000858_altered_metastatic_potential | 0.92889559 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 0.92652956 |
| 83 | MP0009763_increased_sensitivity_to | 0.92140830 |
| 84 | MP0002132_abnormal_respiratory_system | 0.90223001 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.90154594 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.89503154 |
| 87 | MP0005410_abnormal_fertilization | 0.89261912 |
| 88 | MP0000604_amyloidosis | 0.87884724 |
| 89 | MP0005448_abnormal_energy_balance | 0.86742872 |
| 90 | MP0008469_abnormal_protein_level | 0.86422228 |
| 91 | MP0008260_abnormal_autophagy | 0.80823141 |
| 92 | MP0002933_joint_inflammation | 0.79603480 |
| 93 | MP0002419_abnormal_innate_immunity | 0.79060383 |
| 94 | MP0003448_altered_tumor_morphology | 0.78932668 |
| 95 | MP0008874_decreased_physiological_sensi | 0.78857813 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.77948605 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.77826812 |
| 98 | MP0006082_CNS_inflammation | 0.77778519 |
| 99 | MP0000249_abnormal_blood_vessel | 0.77552514 |
| 100 | MP0004272_abnormal_basement_membrane | 0.77523325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.71979028 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.00609233 |
| 3 | Distal lower limb amyotrophy (HP:0008944) | 6.76406362 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.21310188 |
| 5 | Muscle fiber splitting (HP:0003555) | 6.09910048 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.11125031 |
| 7 | Lower limb amyotrophy (HP:0007210) | 5.01456560 |
| 8 | Complement deficiency (HP:0004431) | 4.61205067 |
| 9 | Nemaline bodies (HP:0003798) | 4.40230344 |
| 10 | Difficulty climbing stairs (HP:0003551) | 4.35474687 |
| 11 | Abnormality of complement system (HP:0005339) | 4.13469583 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 4.06504601 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.83715546 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.80210479 |
| 15 | Distal upper limb amyotrophy (HP:0007149) | 3.55845389 |
| 16 | Upper limb amyotrophy (HP:0009129) | 3.55845389 |
| 17 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.51272257 |
| 18 | Neck muscle weakness (HP:0000467) | 3.41890417 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.40519096 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.30957065 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 3.30061535 |
| 22 | Axonal loss (HP:0003447) | 3.29885657 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 3.21885611 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.16331813 |
| 25 | Xanthomatosis (HP:0000991) | 3.04326687 |
| 26 | Joint hemorrhage (HP:0005261) | 2.93523761 |
| 27 | Glomerulonephritis (HP:0000099) | 2.74458412 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74413738 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.73067179 |
| 30 | Bulbar palsy (HP:0001283) | 2.71993749 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.65183072 |
| 32 | Increased muscle lipid content (HP:0009058) | 2.57913465 |
| 33 | Increased connective tissue (HP:0009025) | 2.55295145 |
| 34 | Limb-girdle muscle atrophy (HP:0003797) | 2.48620779 |
| 35 | Exercise-induced myalgia (HP:0003738) | 2.48532424 |
| 36 | Amyloidosis (HP:0011034) | 2.46463405 |
| 37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.46292296 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.41561568 |
| 39 | Hypertriglyceridemia (HP:0002155) | 2.35201938 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.29582697 |
| 41 | Scapular winging (HP:0003691) | 2.28361564 |
| 42 | Generalized amyotrophy (HP:0003700) | 2.28140722 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22873422 |
| 44 | Progressive muscle weakness (HP:0003323) | 2.21920190 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.20453631 |
| 46 | Acanthosis nigricans (HP:0000956) | 2.16056653 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.15617125 |
| 48 | Foot dorsiflexor weakness (HP:0009027) | 2.12408687 |
| 49 | Myocardial infarction (HP:0001658) | 2.11486289 |
| 50 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09215959 |
| 51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07864328 |
| 52 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07864328 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06787741 |
| 54 | Insulin resistance (HP:0000855) | 2.04629976 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02439447 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02439447 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02439447 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 1.98911488 |
| 59 | Spinal rigidity (HP:0003306) | 1.98634856 |
| 60 | Acute necrotizing encephalopathy (HP:0006965) | 1.98190942 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 1.96289981 |
| 62 | Myoglobinuria (HP:0002913) | 1.95739025 |
| 63 | Abnormality of the foot musculature (HP:0001436) | 1.94274199 |
| 64 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.94257427 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93994250 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92771671 |
| 67 | Short nail (HP:0001799) | 1.91823411 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 1.91445855 |
| 69 | Increased serum pyruvate (HP:0003542) | 1.88122245 |
| 70 | Hepatic necrosis (HP:0002605) | 1.87203327 |
| 71 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87027361 |
| 72 | Hypobetalipoproteinemia (HP:0003563) | 1.86672762 |
| 73 | Weak cry (HP:0001612) | 1.82850245 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 1.82743437 |
| 75 | Hypolipoproteinemia (HP:0010981) | 1.81419731 |
| 76 | Hepatocellular necrosis (HP:0001404) | 1.79930009 |
| 77 | Lipoatrophy (HP:0100578) | 1.78592960 |
| 78 | Acute encephalopathy (HP:0006846) | 1.77707793 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 1.77345656 |
| 80 | Bone cyst (HP:0012062) | 1.77312525 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 1.74994638 |
| 82 | Hemorrhage of the eye (HP:0011885) | 1.74327704 |
| 83 | Myopathic facies (HP:0002058) | 1.73179977 |
| 84 | Azoospermia (HP:0000027) | 1.72260848 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.70316248 |
| 86 | Muscle stiffness (HP:0003552) | 1.69493890 |
| 87 | Abnormality of glycolysis (HP:0004366) | 1.68955479 |
| 88 | Palpitations (HP:0001962) | 1.68771102 |
| 89 | Vertebral compression fractures (HP:0002953) | 1.68628430 |
| 90 | Mitochondrial inheritance (HP:0001427) | 1.67772291 |
| 91 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67481468 |
| 92 | Atrioventricular block (HP:0001678) | 1.67177326 |
| 93 | Cholecystitis (HP:0001082) | 1.65786535 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 1.65786535 |
| 95 | Subcapsular cataract (HP:0000523) | 1.65561912 |
| 96 | Hyperammonemia (HP:0001987) | 1.64004402 |
| 97 | Metaphyseal dysplasia (HP:0100255) | 1.62583760 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 1.62538286 |
| 99 | Difficulty running (HP:0009046) | 1.62433271 |
| 100 | Exercise intolerance (HP:0003546) | 1.61260154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.96897183 |
| 2 | IRAK3 | 3.90263117 |
| 3 | ARAF | 3.25792517 |
| 4 | MOS | 3.10582759 |
| 5 | ERN1 | 3.06952098 |
| 6 | TGFBR2 | 2.80960322 |
| 7 | TAOK2 | 2.69702591 |
| 8 | TESK1 | 2.68611499 |
| 9 | TTN | 2.66785232 |
| 10 | NEK1 | 2.47739009 |
| 11 | PIM2 | 2.46172666 |
| 12 | LATS2 | 2.45856832 |
| 13 | PDK2 | 2.33939187 |
| 14 | MAP3K3 | 2.31968591 |
| 15 | ABL2 | 2.13892799 |
| 16 | PBK | 2.08271532 |
| 17 | PINK1 | 2.03784106 |
| 18 | PRPF4B | 1.95490876 |
| 19 | AKT2 | 1.89599193 |
| 20 | MYLK | 1.75409213 |
| 21 | RIPK1 | 1.59914767 |
| 22 | STK16 | 1.47073280 |
| 23 | MST1R | 1.44933042 |
| 24 | EPHB1 | 1.42673997 |
| 25 | EPHB2 | 1.42661502 |
| 26 | LIMK1 | 1.41658872 |
| 27 | GRK7 | 1.40798017 |
| 28 | MUSK | 1.40780500 |
| 29 | PHKG1 | 1.33952739 |
| 30 | PHKG2 | 1.33952739 |
| 31 | PAK4 | 1.33354849 |
| 32 | OBSCN | 1.29509786 |
| 33 | TBK1 | 1.27776029 |
| 34 | TESK2 | 1.27340545 |
| 35 | MAP3K1 | 1.24886583 |
| 36 | BCKDK | 1.17352064 |
| 37 | CLK1 | 1.14607813 |
| 38 | MAP3K13 | 1.09387501 |
| 39 | MAP3K12 | 1.08000193 |
| 40 | MAP2K3 | 1.06272049 |
| 41 | EIF2AK3 | 0.97006918 |
| 42 | ERBB4 | 0.95489763 |
| 43 | PTK2 | 0.89827741 |
| 44 | BRAF | 0.88889582 |
| 45 | TIE1 | 0.87546921 |
| 46 | DDR2 | 0.85574451 |
| 47 | TAOK1 | 0.84003020 |
| 48 | MARK3 | 0.82441667 |
| 49 | EPHA2 | 0.81171946 |
| 50 | MAP3K9 | 0.79719890 |
| 51 | DAPK3 | 0.79289349 |
| 52 | EPHA3 | 0.79106825 |
| 53 | IRAK2 | 0.78622313 |
| 54 | ILK | 0.77225424 |
| 55 | GRK1 | 0.75591944 |
| 56 | MAP3K11 | 0.74093078 |
| 57 | CDC42BPA | 0.73830957 |
| 58 | CAMK2G | 0.72432214 |
| 59 | TRIB3 | 0.72347337 |
| 60 | LMTK2 | 0.72058043 |
| 61 | MAPKAPK3 | 0.66368168 |
| 62 | MST4 | 0.66046149 |
| 63 | PIK3CG | 0.64177114 |
| 64 | GSK3A | 0.62987717 |
| 65 | PRKAA2 | 0.62279353 |
| 66 | EIF2AK1 | 0.61766110 |
| 67 | SIK1 | 0.60299805 |
| 68 | MAPK12 | 0.59892420 |
| 69 | KDR | 0.55408187 |
| 70 | CAMK2D | 0.53735165 |
| 71 | BUB1 | 0.53706536 |
| 72 | VRK2 | 0.53628488 |
| 73 | PAK1 | 0.52564472 |
| 74 | MAP3K5 | 0.51169587 |
| 75 | GRK5 | 0.51050253 |
| 76 | IRAK1 | 0.50831140 |
| 77 | DMPK | 0.50253033 |
| 78 | MAP3K6 | 0.50096078 |
| 79 | ROCK1 | 0.49111672 |
| 80 | STK10 | 0.48343849 |
| 81 | BMX | 0.46316479 |
| 82 | PDPK1 | 0.46118016 |
| 83 | PRKG2 | 0.46111853 |
| 84 | ADRBK1 | 0.45909013 |
| 85 | MAPK4 | 0.43587901 |
| 86 | PAK2 | 0.42700385 |
| 87 | ROCK2 | 0.41493823 |
| 88 | IKBKB | 0.39179518 |
| 89 | ICK | 0.38501966 |
| 90 | CDK8 | 0.35496140 |
| 91 | JAK1 | 0.33731179 |
| 92 | PKN1 | 0.31300195 |
| 93 | CSK | 0.31032149 |
| 94 | DAPK1 | 0.30315101 |
| 95 | MAPKAPK2 | 0.29938300 |
| 96 | MAP3K8 | 0.29152533 |
| 97 | CDK9 | 0.24975798 |
| 98 | RAF1 | 0.24902702 |
| 99 | CAMK2B | 0.24666004 |
| 100 | MET | 0.24413925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.60548890 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.41812173 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.97991069 |
| 4 | * Mineral absorption_Homo sapiens_hsa04978 | 2.97018501 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43316019 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39145487 |
| 7 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.32319308 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24077368 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23687343 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19631043 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.19545233 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03984360 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00000767 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89803046 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.87306524 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77823117 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77078051 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73487402 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.72010785 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70122958 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.67927001 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67852136 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67654103 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.63413499 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62211377 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62117086 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58961907 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52665867 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44714121 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41966601 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.37688669 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34987764 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34524035 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33663616 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.29106205 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26400937 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25525734 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17605338 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17539165 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.17203404 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17180149 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16931771 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16295126 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11343435 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.06639516 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02865130 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02807916 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.01192007 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99779150 |
| 50 | Ribosome_Homo sapiens_hsa03010 | 0.99315904 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99311589 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95629683 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91822551 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91725473 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90734023 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.88780960 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88246466 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86030191 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85890300 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83760747 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81730103 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79758223 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79223088 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79203101 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78502131 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76555561 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75667443 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74615835 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74292071 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.73513924 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.71392286 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69909990 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67849867 |
| 74 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67266680 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67140695 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66114018 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65399018 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61188784 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60524834 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59663304 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56118506 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55278351 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54695879 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49661739 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.47169315 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46474622 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46434989 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45434683 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43218779 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39212110 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.38571668 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.36215119 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35025770 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31910411 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.24536138 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23671763 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22439549 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22089394 |
| 99 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.21976520 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21530878 |

